US-based biotechnology company Mind Medicine (MindMed) has dosed the first subject in the 52-week Phase III Voyage study of ...

Stimulant medications and certain therapies are more effective in treating ADHD symptoms than placebos, a new study on more ...

Across treatments, rozanolixizumab and batoclimab were most effective, though rozanolixizumab carried increased risk of ...